BlackRock Health Sciences Trust II (NYSE:BMEZ) Short Interest Update

BlackRock Health Sciences Trust II (NYSE:BMEZ – Get Rating) was the recipient of a significant growth in short interest during the month of December. As of December 30th, there was short interest totalling 25,900 shares, a growth of 56.0% from the December 15th total of 16,600 shares. Based on an average daily trading volume, of 534,500 shares, the days-to-cover ratio is currently 0.0 days.

BlackRock Health Sciences Trust II Price Performance

BMEZ opened at 16.51 on Friday. The company’s 50-day moving average is 15.82 and its 200 day moving average is 16.02. BlackRock Health Sciences Trust II has a fifty-two week low of 14.33 and a fifty-two week high of 22.49.

BlackRock Health Sciences Trust II Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, January 31st. Shareholders of record on Friday, January 13th will be given a $0.145 dividend. This represents a $1.74 annualized dividend and a yield of 10.54%. The ex-dividend date is Thursday, January 12th.

Institutional Trading of BlackRock Health Sciences Trust II

Several hedge funds have recently added to or reduced their stakes in BMEZ. Nelson Van Denburg & Campbell Wealth Management Group LLC bought a new stake in shares of BlackRock Health Sciences Trust II in the third quarter valued at approximately $29,000. MUFG Americas Holdings Corp purchased a new position in BlackRock Health Sciences Trust II during the third quarter valued at approximately $30,000. Arlington Partners LLC purchased a new position in BlackRock Health Sciences Trust II during the fourth quarter valued at approximately $46,000. Blue Bell Private Wealth Management LLC grew its stake in BlackRock Health Sciences Trust II by 62.9% in the 2nd quarter. Blue Bell Private Wealth Management LLC now owns 7,422 shares of the company’s stock worth $122,000 after buying an additional 2,867 shares in the last quarter. Finally, Dowling & Yahnke LLC purchased a new position in BlackRock Health Sciences Trust II in the 3rd quarter worth approximately $149,000.

About BlackRock Health Sciences Trust II

(Get Rating)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.